1. Personal History
1.1 Patients Profile
Name: Mr. Ajay Chaturvedi
Age: 50 years old
Sex: Male
Civil Status: Married
Religion: Roman Catholic
Date of Admission: February 04, 2014
Room No. : 532
Complaints: tonsillitis
Diagnosis: Acute Myelogenous Leukemia
1.2Family and individual information, social and health history
Mr. Ajay, 50 yrs. Old, male, Filipino Roman Catholic, who is married and has four children, all of
which are still schooling. The patient works in a government office. The patient is always exposed in
petroleum products and paints. Mr. Ajay is not hypertensive, diabetic and asthmatic. He is an occasional
drinker and a positive smoker which he consumes one pack per day. Mr. Ajay was rushed in the
emergency room of Cebu Doctor’s University Hospital because he fainted and was very pale. He also
complains of tonsillitis.
1.3. Level of growth and Development
HAIR Evenly
distributed,
Black in color,
short, straight
hair, smooth
FACE Presence of
pimples noted,
No wrinkles,
brown in color
EYELASHES Equally
distributed
LACRIMAL Pale, no
discharges
EXTREMITIES:
UPPER: Without IV, can
perform limited
ROM exercises,
petechiae was
noted (pin point
like appearance)
HEART
BP: 100/60
mmhg
Clear breath
LUNGS
sounds
ABDOMEN Brown in color,
Bowel sounds: 3
no abdominal
upon
distention auscultation
NORMAL
MCHC 33.4-35.5% 35.0%
-- NORMAL
MPV --
-- -- NORMAL
RDW
Platelet Count 150,000-450,000/cu Decreased: Acute
27,020/cu mm
Leukemia
mm
Reticulocyte -- NORMAL
0.5-1.5%
-- NORMAL
ESR
0.00-20.00mm/h
Increased: Fever
Creatinine Serum 2.1 mg/dL
0.7-1.5mg/dL
Decreased: Diarrhea
Potassium 3.0 mmol/L
3.6-5.0mmol/L
ALT 11-66uL 59 uL NORMAL
Sodium 137-145mmol/L 134 mmol/L Decreased: Metabolic
Acidosis
Before the patient was diagnosed with Acute Myelogenous Leukemia the patient
describes himself as a healthy individual. But as of now, he describes his condition as very poor due to
his present condition. In order for him to keep healthy, he must eat nutritious foods and must not over
fatigue himself. He follows the doctors order and take the medication as needed. The patient refuses to
Before the patient was not admitted in the hospital, he likes to eat any kind of foods. But
as of now, the patient does not want to eat and he vomits all the time. The patient drinks alcohol mostly
everyday, he prefers to drink Tanduay and Emperador. The patient also smokes and can consume one
pack per day. The patient takes vitamin supplements like Revicon and Everet. According to the patient his
On the first week of his admission, the patient was having hematuria and melena. After
the following weeks, the patient’s foley bag catheter was already removed and the patient was
having no problems in urinating and defecating. The patient defecates once in a day.
Before, the patient used to walk from his home to his office, but now even five steps he feels
fatigue and will have a difficulty in breathing. The patient was advised by the physician not to over
The patient cannot see from far objects. He wears eyeglasses so that he can see clearly. The
patient can hear well enough. The patient often times complains of fatigue and feels drowsy all the time.
now because of his condition he sleeps most of the time. The patient has no problem in sleeping.
The patient is concerned about his illness. He is scared that he will die and might be far
away from his family. According to the patient, he wants to be free from Leukemia but it is too
impossible to happen, it needs some miracles. The patient describes himself as very religious especially
with his condition and he must need some faith to hold on to whatever circumstances might happen. His
condition made him different because unlike normal people he needs to wear a mask all the time.
The patient prefers to speak Cebuano. He speaks clearly and fluently and he is able to
express himself freely. The patient lives with his family in Matab-ang Toledo City.
3.9 Coping or stress Tolerance Pattern
The patient and his wife both make the decision especially when it comes to health and
financial matters. He sometimes seeks help to his mother when it comes t o problem solving because he
is more comfortable in asking for assistance so that he can express his feelings. The patient is still
The patient is a Roman Catholic and God is very important to him. For him, God and his
family is his source of strength and meaning. The patient prays the rosary and attends mass every
Sunday. The patient wishes to go to Simala to pray for his condition. According to the patient, he just
One part of the immune system uses barriers to protect the body from foreign substances. These
barriers include the skin and the mucous membranes, which line all body cavities; and protective
chemicals, such as enzymes in saliva and tears that destroy bacteria. Another part of the
immune system uses lymphocytes, specialized white blood cells that respond to specific types of
foreign invaders. B lymphocytes produce proteins called antibodies, which circulate in the blood
and attack specific disease-causing organisms. T lymphocytes attack invading organisms directly.
BONE MARROW
Bone Marrow, soft, pulpy tissue that fills the cavities of bones, occurring in two forms,
red and yellow. One of the largest tissues in the body, bone marrow accounts for 2 to 5 percent of
an adult’s weight. Red marrow, present in all bones at birth, serves as the blood manufacturing
center. As an infant matures, most of the red marrow in the shaft of long bones, such as the arm
and leg bones, is gradually replaced by yellow marrow. Yellow marrow is composed primarily of
STRUCTURE
Red marrow consists primarily of a loose, soft network of blood vessels and protein
fibers interspersed with developing blood cells. The blood vessels are termed the vascular
component, and the protein fibers and developing blood cells collectively are referred to as the
stroma, or the extravascular component. The protein fibers crisscross the marrow, forming a
meshwork that supports the developing blood cells clustered in the spaces between the fibers.
Red marrow contains a rich blood supply. Arteries transport blood containing oxygen and
nutrients into the marrow, and veins remove blood containing carbon dioxide and other wastes.
The arteries and veins are connected by capillaries, blood vessels that branch throughout the
marrow. In various places, the capillaries balloon out, forming numerous thin, blood-filled
cavities. These cavities are called sinusoids, and they assist in blood-cell production.
rich mesh of connective tissue that also supports many blood vessels. While not usually actively
MARROW FUNCTION
Red marrow produces all of the body’s blood cells—red blood cells, white blood cells,
and platelets. Red blood cells in the circulatory system transport oxygen to body tissues and
carbon dioxide away from tissues. White blood cells are critical for fighting bacteria and other
foreign invaders of the body .Platelets are essential for the formation of blood clots to heal
wounds. Within red bone marrow, all blood cells originate from a single type of cell, called a
hematopoietic stem cell. Stimulated by hormones and growth factors, these stem cells divide to
produce immature, or progenitor blood cells. Most of these progenitor cells remain in the stroma
and rapidly undergo a series of cell divisions, producing either red blood cells or white blood
cells. At any one time, the stroma consists largely of progenitor cells in various stages of
development. At the appropriate developmental stage, the fresh, new cells squeeze through the
walls of the capillaries. From there, the cells leave the bone and enter the body’s circulatory
system. Some progenitor cells migrate to the sinusoids, where they produce platelets, which also
travel to the circulatory system via the capillaries. Although stem cells are relatively rare—about
1 in every 10,000 marrow cells is a stem cell—they typically produce the forerunners of an
estimated 2 million red cells per second and 2 billion platelets per day. However, if significant
amounts of blood are lost or other conditions reduce the supply of oxygen to tissues, the kidneys
secrete the hormone erythropoietin. This hormone stimulates stem cells to produce more red
blood cells. To fight off infection, hormones collectively termed colony stimulating growth
factors are released by the immune system. These hormones stimulate the stem cells to produce
more infection-fighting white blood cells. And in severe cases, the body converts yellow marrow
4.3 Discuss the disease process ands its effects on different organ/system
Leukemia Overview
CANCER
LEUKEMIA
Normal blood contains 3 major groups of cells: white blood cells, red blood cells, and platelets.
All 3 types of blood cells develop from one immature cell type, called blood/marrow stem cells,
in a process called hematopoiesis.
These stem cells divide and develop to a more developed, but still immature precursor, called a
blast, which then develops through several more stages, into a mature blood cell.
This process takes place in the bone marrow, which is the soft spongy material found in the
center of most bones.
Each type of blood cells has its own different and essential function in the body.
White blood cells (leukocytes) are part of the immune system and help fight a variety of
infections. They also help in the healing of wounds, cuts, and sores.
Red blood cells (erythrocytes) contain hemoglobin, which carries oxygen to, and removes carbon
dioxide from, the cells throughout the various organs of the body.
Platelets, along with certain plasma proteins, help plug the holes in blood vessels and form clots
once blood vessels are damaged or cut.
The first step in the process of stem cell maturation is differentiation into 2 groups: the myeloid stem cell
line and the lymphoid stem cell line.
The myeloid stem cells, or lineage, develop into red blood cells, platelets, and certain types of
white blood cells (granulocytes or monocytes).
The lymphoid stem cells, or lineage, develop into another type of white blood cell
(lymphocytes).
Either lineage can be affected by leukemia. Leukemias that affect the myeloid lineage are called
myelocytic (also myelogenous, myeloblastic, or nonlymphocytic) leukemias. Leukemias that
affect the lymphoid lineage are called lymphocytic (also lymphoblastic or lymphogenous)
leukemias.
Each of the 2 major types of leukemia, myelogenous and lymphocytic, include both acute and chronic
forms.
Acute essentially refers to a disorder of rapid onset. In the acute myelocytic leukemias, the
abnormal cells grow rapidly and do not mature. Most of these immature cells tend to die rapidly.
In the acute lymphocytic leukemias, growth is not as rapid as that of the myelocytic cells. Rather,
the cells tend to accumulate. Common to both types of leukemia is their inability to carry out the
functions of healthy white blood cells. Untreated, death occurs within weeks or a few months.
In the chronic leukemias, the onset tends to be slow, and the cells generally mature abnormally
and often accumulate in various organs, often over long intervals. Their ability to fight infections
and assist in repairing injured tissues is impaired. However, unlike the acute forms of leukemia,
untreated, these disorders may persist for many months or, as in the chronic lymphocytic group,
many years. A distinctive feature of the chronic myelocytic type is its invariable conversion, if
untreated, to a more rapidly fulminating acute type, leading to rapid death.
WHAT HAPPENS IN LEUKEMIA?
When a large number of blasts (leukemic cells) appear in the bone marrow, several
things happen. As the leukemic blast cells accumulate in the bone marrow, they begin to crowd
out the normal blood cells that develop there. Eventually, they take up so much room that red
blood cells, platelets, and normal white blood cells cannot be produced. When that happens, the
young person develops symptoms indicating that normal blood cells are not being manufactured
in adequate numbers:
If red blood cells are crowded out by leukemic cells, the blood will look thin, which makes the
patient look pale. The young person also may be tired, because the thin blood cannot carry
enough oxygen to the heart, lungs, and muscles.
If blood platelets are crowded out in the bone marrow, the young person may have bleeding
problems and unusual bruising.
If the normal, mature kind of white cells known as neutrophils are crowded out by the blasts,
there will be no cells to combat bacteria, and infections may occur.
In some cases, leukemic blasts may spill over from the bone marrow into the blood, where they
can be seen by microscopic examination. This may cause a rise in the number of white cells in
the blood (the white blood cell count). In other cases, only a few blasts appear in the blood, and
the white cell count does not change much. When leukemic blasts are present in the blood, they
may be carried to other places in the body and enter various body organs. Sometimes they grow
in these organs as well as in the bone marrow.
Acute myelogenous leukemia (AML) is a cancer of the blood and bone marrow — the spongy
tissue inside bones where blood cells are made.
It's called acute leukemia because it progresses rapidly and affects immature blood cells,
rather than mature ones. It's called myelogenous (MI-uh-loj-uh-nus) leukemia because it affects a
group of white blood cells called the myeloid cells, which normally develop into the various
types of mature blood cells, such as red blood cells, white blood cells and platelets. This type of
leukemia is also known as acute myeloid leukemia, acute myeloblastic leukemia, acute
granulocytic leukemia and acute nonlymphocytic leukemia.
Normally, your bone marrow produces immature cells (stem cells) in a controlled way, and they
mature and specialize into the various types of blood cells as needed. In people with acute
myelogenous leukemia, the bone marrow produces immature cells that usually develop into a
type of abnormal white blood cell. These abnormal cells aren't able to mature and perform their
usual functions. Even worse, they multiply rapidly and can crowd out healthy cells, leaving a
person with acute myelogenous leukemia vulnerable to infection, anemia or easy bleeding.
Leukemia cells can also spread outside the blood to other parts of your body.Acute myelogenous
leukemia is the most common form of leukemia. It worsens quickly if not treated, but it initially
responds well to treatment. Unfortunately, many people with acute myelogenous leukemia
experience a relapse. Much research is focused on decreasing the risk of relapse and improving
the long-term outcomes for people with acute myelogenous leukemia
CAUSES
The cause of acute myelogenous leukemia is damage to the DNA of developing cells in
your bone marrow. Under normal circumstances, your DNA is like a set of instructions for your
cells, telling them how and when to grow and divide. Certain genes on your DNA called
oncogenes promote cell division. Other genes, called tumor suppressor genes, slow down cell
division and cause cells to die at the appropriate times.
Acute myelogenous leukemia can occur when damage to DNA turns on oncogenes or turns off
tumor suppressor genes. When this happens, blood cell production goes awry. The bone marrow
produces immature cells that develop into leukemic white blood cells called myeloblasts. These
abnormal cells are unable to function properly, and they can build up and crowd out healthy
cells.The DNA mutations that cause leukemia are usually acquired — rather than inherited —
but researchers and doctors don't always understand exactly how. In some cases, damage to DNA
is the result of exposure to cancer-causing chemicals, including previous chemotherapy for other
cancers. There's also a chance of AML progressing from other blood diseases and chronic
leukemias, such as chronic myelogenous leukemia, myelodysplasia or other disorders in which
the bone marrow produces too much of certain types of blood cells (myeloproliferative
disorders).
RISK FACTORS
The risk of acute myelogenous leukemia increases with age. It's most prevalent in people in
their 60s and older. The disorder is also more common in males than in females. Other possible
risk factors include:
Cancer therapy. People who've had certain types of chemotherapy and radiation therapy or
treatment for childhood acute lymphocytic leukemia (ALL) may have a greater risk of developing
AML.
Exposure to radiation and certain chemicals. People exposed to very high levels of radiation,
such as survivors of an atomic bomb blast or a nuclear reactor accident, have an increased risk of
developing AML. Exposure to certain chemicals, such as benzene — which is found in unleaded
gasoline and used by the chemical industry — also is linked to greater risk of AML.
Smoking. AML is linked to cigarette smoke, which contains benzene and other known cancer-
causing chemicals. Smokers older than 60 face twice the risk of AML that nonsmokers do.
Other blood disorders. People who've had another blood disorder, such as myelodysplasia,
polycythemia vera or thrombocythemia, are at greater risk of developing AML.
Genetic disorders. Certain genetic disorders, such as Down syndrome, are associated with an
increased risk of AML.
Nursing Interventions
TREATMENT
Treatment of patients with acute myelogenous leukemia depends on age and the subtype of
Remission induction therapy. The purpose of the first phase of treatment is to kill the leukemia
cells in your blood and bone marrow. However, remission induction usually doesn't wipe out all
of the leukemia cells, so you need further treatment to prevent the disease from returning.
intensification, this phase of treatment is aimed at destroying the remaining leukemia cells. It's
If you have AML, you'll probably stay in the hospital during the treatment cycle because
the chemotherapy destroys many normal blood cells in the process of killing leukemia
cells. This chemotherapy can cause anemia, infection and bleeding. If the first cycle of
treatment doesn't cause remission, you may need it repeated one or two more times. Other
Chemotherapy can also be used for consolidation therapy. This phase may include a
combination of different medications that mimic the induction, but usually includes high
doses of cytarabine by itself for one to three cycles. Your doctor may also prescribe
medications that boost white cell production to reduce the risk of infection. These
Other drug therapy. Arsenic trioxide and all-trans retinoic acid (ATRA) are anti-cancer drugs that
certain subtype of AML called promyelocytic leukemia. These drugs cause leukemia cells with a
Biological therapy. Also known as immunotherapy, biological therapy uses substances that
bolster your immune system's response to cancer. Monoclonal antibodies are one form of
biological therapy. These antibodies are produced in a laboratory, but they mimic protein
products found in your immune system (antibodies) that attack foreign substances (antigens) on
chemical toxin that attaches to AML cells. It's used to treat older people with AML who don't
respond to initial treatment or who relapse after successful initial treatment. Researchers are
Bone marrow transplant. This is another option for consolidation therapy for people at high risk
of relapse or for treating relapse when it occurs. This procedure allows someone with leukemia
to re-establish healthy stem cells by replacing their leukemic bone marrow with leukemia-free
marrow. If you choose this treatment, you'll receive very high doses of chemotherapy or
radiation therapy to destroy your leukemia-producing bone marrow. This marrow is then
replaced by bone marrow from a compatible donor (allogeneic transplant). In some cases, you
may also be able to use your own bone marrow for transplant (autologous transplant). This is
possible if you go into remission and then save healthy bone marrow for a future transplant.
Stem cell transplant. Stem cell transplant is also used for consolidation therapy. It's similar to
bone marrow transplant except the stem cells are collected from circulating blood (peripheral
blood), rather than from the bone marrow, thanks to a medication that causes larger numbers of
stem cells to be released from the bone marrow. The cells used for transplant can be your own
healthy cells, or they can be collected from a compatible donor. This procedure is used more
frequently than bone marrow transplant because of shortened recovery times and possible
Radiation Therapy.Radiation therapy involves the use of radiation to kill cancer cells
and shrink tumors. For AML, external radiation therapy is used.In external radiation
therapy radiation is directed at the tumor from a source outside the body. This type of
treatment is used for AML that has spread—or may spread—to the brain and spinal cord.
It can also be used to treat bone pain that comes from bone affected by the leukemia.
NCP
NURSING CARE PLAN
After 45 minutes of
student nurse-patient
interaction, the patient
will be able to:
3. determine the
significance Informal
on wearing a 3. significance on wearing
mask all the time discussion
mask all the
time 3.1 this is to prevent the
patient from acquiring
4. the patient will any infection
show interest 4. shows interest during the Informal
during the health teaching discussion and
health 4.1 asks questions during the utilization of
teaching interaction of the student pictures
nurse
4.2 participates and
encourages the student
nurse to go on to the
discussion
4.3 Shows interest on the
discussion by
cooperating with the
student nurse
5. clustering scheduled
5. demonstrate activities
beginning 5.1 teach client on how to Scheduling
skills on cluster activities to activities and
preventing prevent fatigue example: Informal
fatigue by Monday: 7:00-7:30 discussion
clustering (eating breakfast)
scheduled 7:30 – 9:00 watching
activities television for relaxation
9:00-9:30 perform
exercise such as walking
9:30-10:00 reading
books …
5.2 let the patient decide
and schedule his planned activities
VII. Evaluation and Recommendation:
knowledge regarding a condition of a disease may hinder a patient in seeking immediate advice
from medical specialist. Fear and financial problems may sometimes interfere which may often
This I believe is one of the major causes as to why my patient has gone to this terminal
stage of his Acute Myelogenous Leukemia (AML). The nature of his job as a painter exposes
him to great risk of an organ damage. Petroleum products when exposed to a person to a
considerable period of time may often lead a person to this problem. This is also coupled with
According to his recent laboratory results, his platelet is 27,000 /cu mm which is very
low compared to the normal platelet count of 150,000-450,000/ cu mm. This shows a decrease in
both platelets and erythrocytes. The patient shows hematuria, melena and petechiae on his both
upper and lower extremities, this is an indication of decrease in platelet as well. Because of lack
of mature and normal granulocytes, the patient had a massive tonsillitis. Since treatment for
chemotherapy is too costly for the patient this could contribute for a compelling severity of his
health condition.
Immaturity of leukocytes can also lead to severe infection, the patient is encouraged to wear
mask whenever the condition necessitates. The patient needs proper rest due to fatigue. He also
needs more encouragement from his immediate family member, relatives and friends.
Government sector plays a great role in sustaining financial support for indigent patients.
Health care institutions can also help in the financial assistance of their members. Advancement
of medical technology and profession is always a mileage in the science of medical world.
Bibliography
INTERNET:
http://healthgate.partners.org
www.mayoclinic.com
www.cancerlinkusa.com
www.niaid.nih.gov]